Recombinant Activated Factor VII as a Second Line Treatment for Postpartum Hemorrhage

BACKGROUND: Severe or massive postpartum hemorrhage (PPH) has remained a leading cause of maternal mortality for decades across the world and it results in critical obstetric complications. Recombinant activated factor VII (rFVIIa) has emerged as a gold standard adjunctive hemostatic agent for the t...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Soon Chang, Yeom, Seok Ran, Han, Sang Kyoon, Jo, Young Mo, Kim, Hyung Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Critical Care Medicine 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6786683/
https://www.ncbi.nlm.nih.gov/pubmed/31723654
http://dx.doi.org/10.4266/kjccm.2016.00787

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6786683/
https://www.ncbi.nlm.nih.gov/pubmed/31723654
http://dx.doi.org/10.4266/kjccm.2016.00787

Ejemplares similares